Nix

Nix Biosensors develops wearable sweat-analysis hardware and software that quantify fluid and electrolyte loss in real time. The core product, the Hydration Biosensor, pairs a reusable electronic pod weighing under 0.5 ounces with a single-use, disposable sweat patch that adheres to the skin with kinesiology tape. The patch collects sweat in a flow channel and measures electrochemical biomarkers, sweat rate, electrolyte loss rate and sweat composition each second while the wearer is actively sweating; the pod streams that data to the Nix mobile app every second and has a battery life of up to 36 hours.

The Nix app (iOS and Android) delivers live notifications on when, what and how much to drink, stores each session to a personal sweat profile, and offers historical and predictive views, including the Nix Index, which relates hydration needs to environmental conditions and can be forecast for a future workout. The app can also recommend a commercial hydration product matched to the user's sweat composition or a custom formulation. Integrations launched with Apple Watch, Garmin watches and Garmin Edge bike computers, with Strava, TrainingPeaks, Wahoo and Zwift listed as planned.

The company sells three offerings: Nix Solo for individual athletes, Nix Pro for coaches, nutritionists or supervisors monitoring multiple subjects through a group dashboard, and Nix Health, an in-development algorithmic hydration intelligence product intended to be licensed to third-party consumer health platforms so users can receive hydration recommendations without wearing a Nix sensor. Nix has also identified lactate, cortisol, glucose, Vitamin D, testosterone and estrogen as additional sweat-detectable biomarkers it plans to research.

Founding story

Founder and CEO Meridith Cass, a Harvard Business School graduate, former venture capitalist, collegiate athlete and nine-time marathoner, developed the Hydration Biosensor after experiencing hyponatremia (over-hydration) during the Boston Marathon and finding few options available for hydration monitoring.

Business model

Nix sells hardware direct to consumers through its own online store: a $189 Hydration Biosensor kit (pod, four patches, charging case and USB cord), $25 sweat patch refills, training bundles and gift cards, with free US shipping over $35 and HSA/FSA payment accepted via Flex. Recurring revenue comes from single-use patch refills. A group-monitoring offering, Nix Pro, serves teams and organizations, and the planned Nix Health product would add a software and data licensing model in which Nix's hydration algorithms are embedded in existing consumer health platforms rather than sold with a sensor.

Device sales plus repeat purchases of disposable sweat patches; planned licensing of hydration algorithms to third-party consumer health and wellness platforms.

Traction

The Hydration Biosensor carries an aggregate customer rating of 4.14 out of 5 from 44 reviews on the company's product page. Reviewers report accurate fluid-loss tracking and reliable patch adhesion, while some cite the recurring cost of single-use patches, connectivity or pairing problems and limited in-app explanation of results. Nix reports deployments across athletes, military personnel and workers that have generated a real-world sweat dataset.

Latest developments

Nix closed a $10 million Series A to fund product development, data science and market expansion, with an emphasis on Nix Health, an algorithmic hydration product designed to integrate into existing consumer health platforms without a Nix sweat sensor. Investors include Shorewind Capital, Great Oaks Venture Capital, White Road Investments (the family office of CLIF Bar founders Gary Erickson and Kit Crawford), Anne Wojcicki, Len Blavatnik, and owners of the St. Louis Blues, Boston Celtics, Baltimore Orioles, Boston Legacy FC and Texas Rangers. Part of the round supports research into additional sweat-detectable biomarkers including lactate, cortisol, glucose, Vitamin D, testosterone and estrogen; no timeline for commercial products based on those biomarkers was provided.